Global Human Injection Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to our (Global Info Research) latest study, the global Human Injection Flu Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Human Injection Flu Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Injection Flu Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Injection Flu Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Injection Flu Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Injection Flu Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Human Injection Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Injection Flu Vaccine, with price, sales, revenue and global market share of Human Injection Flu Vaccine from 2018 to 2023.
Chapter 3, the Human Injection Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Injection Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Injection Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Injection Flu Vaccine.
Chapter 14 and 15, to describe Human Injection Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Human Injection Flu Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Human Injection Flu Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Injection Flu Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Human Injection Flu Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Injection Flu Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Injection Flu Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Injection Flu Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- 6 Months to 3 Years
- > 3 Years
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- Jiangsu GDK
- KM Biologics
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Injection Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Injection Flu Vaccine, with price, sales, revenue and global market share of Human Injection Flu Vaccine from 2018 to 2023.
Chapter 3, the Human Injection Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Injection Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Injection Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Injection Flu Vaccine.
Chapter 14 and 15, to describe Human Injection Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Human Injection Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Human Injection Flu Vaccine Market Size & Forecast
1.5.1 Global Human Injection Flu Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Injection Flu Vaccine Sales Quantity (2018-2029)
1.5.3 Global Human Injection Flu Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Human Injection Flu Vaccine Product and Services
2.1.4 Sanofi Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Injection Flu Vaccine Product and Services
2.2.4 CSL Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Human Injection Flu Vaccine Product and Services
2.3.4 GSK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Human Injection Flu Vaccine Product and Services
2.4.4 Viatris Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Human Injection Flu Vaccine Product and Services
2.5.4 AstraZeneca Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Human Injection Flu Vaccine Product and Services
2.6.4 Hualan Bio Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hualan Bio Recent Developments/Updates
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
2.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Institute of Biological Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Human Injection Flu Vaccine Product and Services
2.8.4 Sinovac Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Recent Developments/Updates
2.9 Jiangsu GDK
2.9.1 Jiangsu GDK Details
2.9.2 Jiangsu GDK Major Business
2.9.3 Jiangsu GDK Human Injection Flu Vaccine Product and Services
2.9.4 Jiangsu GDK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Jiangsu GDK Recent Developments/Updates
2.10 KM Biologics
2.10.1 KM Biologics Details
2.10.2 KM Biologics Major Business
2.10.3 KM Biologics Human Injection Flu Vaccine Product and Services
2.10.4 KM Biologics Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN INJECTION FLU VACCINE BY MANUFACTURER
3.1 Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Injection Flu Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Human Injection Flu Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Injection Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Injection Flu Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Human Injection Flu Vaccine Manufacturer Market Share in 2022
3.5 Human Injection Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Injection Flu Vaccine Market: Region Footprint
3.5.2 Human Injection Flu Vaccine Market: Company Product Type Footprint
3.5.3 Human Injection Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Injection Flu Vaccine Market Size by Region
4.1.1 Global Human Injection Flu Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Human Injection Flu Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Human Injection Flu Vaccine Average Price by Region (2018-2029)
4.2 North America Human Injection Flu Vaccine Consumption Value (2018-2029)
4.3 Europe Human Injection Flu Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Human Injection Flu Vaccine Consumption Value (2018-2029)
4.5 South America Human Injection Flu Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Human Injection Flu Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Human Injection Flu Vaccine Consumption Value by Type (2018-2029)
5.3 Global Human Injection Flu Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Human Injection Flu Vaccine Consumption Value by Application (2018-2029)
6.3 Global Human Injection Flu Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Human Injection Flu Vaccine Market Size by Country
7.3.1 North America Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Human Injection Flu Vaccine Market Size by Country
8.3.1 Europe Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Injection Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Human Injection Flu Vaccine Market Size by Country
10.3.1 South America Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Injection Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Human Injection Flu Vaccine Market Drivers
12.2 Human Injection Flu Vaccine Market Restraints
12.3 Human Injection Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Injection Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Injection Flu Vaccine
13.3 Human Injection Flu Vaccine Production Process
13.4 Human Injection Flu Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Injection Flu Vaccine Typical Distributors
14.3 Human Injection Flu Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Human Injection Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Human Injection Flu Vaccine Market Size & Forecast
1.5.1 Global Human Injection Flu Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Injection Flu Vaccine Sales Quantity (2018-2029)
1.5.3 Global Human Injection Flu Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Human Injection Flu Vaccine Product and Services
2.1.4 Sanofi Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Injection Flu Vaccine Product and Services
2.2.4 CSL Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Human Injection Flu Vaccine Product and Services
2.3.4 GSK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Human Injection Flu Vaccine Product and Services
2.4.4 Viatris Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Human Injection Flu Vaccine Product and Services
2.5.4 AstraZeneca Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Human Injection Flu Vaccine Product and Services
2.6.4 Hualan Bio Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hualan Bio Recent Developments/Updates
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
2.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Institute of Biological Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Human Injection Flu Vaccine Product and Services
2.8.4 Sinovac Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Recent Developments/Updates
2.9 Jiangsu GDK
2.9.1 Jiangsu GDK Details
2.9.2 Jiangsu GDK Major Business
2.9.3 Jiangsu GDK Human Injection Flu Vaccine Product and Services
2.9.4 Jiangsu GDK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Jiangsu GDK Recent Developments/Updates
2.10 KM Biologics
2.10.1 KM Biologics Details
2.10.2 KM Biologics Major Business
2.10.3 KM Biologics Human Injection Flu Vaccine Product and Services
2.10.4 KM Biologics Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 KM Biologics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN INJECTION FLU VACCINE BY MANUFACTURER
3.1 Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Injection Flu Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Human Injection Flu Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Injection Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Injection Flu Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Human Injection Flu Vaccine Manufacturer Market Share in 2022
3.5 Human Injection Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Injection Flu Vaccine Market: Region Footprint
3.5.2 Human Injection Flu Vaccine Market: Company Product Type Footprint
3.5.3 Human Injection Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Injection Flu Vaccine Market Size by Region
4.1.1 Global Human Injection Flu Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Human Injection Flu Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Human Injection Flu Vaccine Average Price by Region (2018-2029)
4.2 North America Human Injection Flu Vaccine Consumption Value (2018-2029)
4.3 Europe Human Injection Flu Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Human Injection Flu Vaccine Consumption Value (2018-2029)
4.5 South America Human Injection Flu Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Human Injection Flu Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Human Injection Flu Vaccine Consumption Value by Type (2018-2029)
5.3 Global Human Injection Flu Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Human Injection Flu Vaccine Consumption Value by Application (2018-2029)
6.3 Global Human Injection Flu Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Human Injection Flu Vaccine Market Size by Country
7.3.1 North America Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Human Injection Flu Vaccine Market Size by Country
8.3.1 Europe Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Injection Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Human Injection Flu Vaccine Market Size by Country
10.3.1 South America Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Injection Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Injection Flu Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Human Injection Flu Vaccine Market Drivers
12.2 Human Injection Flu Vaccine Market Restraints
12.3 Human Injection Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Injection Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Injection Flu Vaccine
13.3 Human Injection Flu Vaccine Production Process
13.4 Human Injection Flu Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Injection Flu Vaccine Typical Distributors
14.3 Human Injection Flu Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Human Injection Flu Vaccine Product and Services
Table 6. Sanofi Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Human Injection Flu Vaccine Product and Services
Table 11. CSL Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Human Injection Flu Vaccine Product and Services
Table 16. GSK Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Human Injection Flu Vaccine Product and Services
Table 21. Viatris Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Viatris Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Human Injection Flu Vaccine Product and Services
Table 26. AstraZeneca Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 29. Hualan Bio Major Business
Table 30. Hualan Bio Human Injection Flu Vaccine Product and Services
Table 31. Hualan Bio Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hualan Bio Recent Developments/Updates
Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Institute of Biological Major Business
Table 35. Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
Table 36. Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changchun Institute of Biological Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Human Injection Flu Vaccine Product and Services
Table 41. Sinovac Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Recent Developments/Updates
Table 43. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 44. Jiangsu GDK Major Business
Table 45. Jiangsu GDK Human Injection Flu Vaccine Product and Services
Table 46. Jiangsu GDK Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Jiangsu GDK Recent Developments/Updates
Table 48. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 49. KM Biologics Major Business
Table 50. KM Biologics Human Injection Flu Vaccine Product and Services
Table 51. KM Biologics Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. KM Biologics Recent Developments/Updates
Table 53. Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 54. Global Human Injection Flu Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Human Injection Flu Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Human Injection Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Human Injection Flu Vaccine Production Site of Key Manufacturer
Table 58. Human Injection Flu Vaccine Market: Company Product Type Footprint
Table 59. Human Injection Flu Vaccine Market: Company Product Application Footprint
Table 60. Human Injection Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Human Injection Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 63. Global Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 64. Global Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Human Injection Flu Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Human Injection Flu Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 69. Global Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 70. Global Human Injection Flu Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Human Injection Flu Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Human Injection Flu Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Human Injection Flu Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 75. Global Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 76. Global Human Injection Flu Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Human Injection Flu Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Human Injection Flu Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Human Injection Flu Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 81. North America Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 82. North America Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 83. North America Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 84. North America Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 85. North America Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 86. North America Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 89. Europe Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 90. Europe Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 91. Europe Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 92. Europe Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 93. Europe Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 94. Europe Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 97. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 98. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 99. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 100. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 101. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 102. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 105. South America Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 106. South America Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 107. South America Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 108. South America Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 109. South America Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 110. South America Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 113. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 114. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 115. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 116. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 117. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 118. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Human Injection Flu Vaccine Raw Material
Table 121. Key Manufacturers of Human Injection Flu Vaccine Raw Materials
Table 122. Human Injection Flu Vaccine Typical Distributors
Table 123. Human Injection Flu Vaccine Typical Customers
Table 1. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Human Injection Flu Vaccine Product and Services
Table 6. Sanofi Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Human Injection Flu Vaccine Product and Services
Table 11. CSL Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Human Injection Flu Vaccine Product and Services
Table 16. GSK Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Human Injection Flu Vaccine Product and Services
Table 21. Viatris Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Viatris Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Human Injection Flu Vaccine Product and Services
Table 26. AstraZeneca Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 29. Hualan Bio Major Business
Table 30. Hualan Bio Human Injection Flu Vaccine Product and Services
Table 31. Hualan Bio Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hualan Bio Recent Developments/Updates
Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Institute of Biological Major Business
Table 35. Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
Table 36. Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changchun Institute of Biological Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Human Injection Flu Vaccine Product and Services
Table 41. Sinovac Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Recent Developments/Updates
Table 43. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 44. Jiangsu GDK Major Business
Table 45. Jiangsu GDK Human Injection Flu Vaccine Product and Services
Table 46. Jiangsu GDK Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Jiangsu GDK Recent Developments/Updates
Table 48. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 49. KM Biologics Major Business
Table 50. KM Biologics Human Injection Flu Vaccine Product and Services
Table 51. KM Biologics Human Injection Flu Vaccine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. KM Biologics Recent Developments/Updates
Table 53. Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 54. Global Human Injection Flu Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Human Injection Flu Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Human Injection Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Human Injection Flu Vaccine Production Site of Key Manufacturer
Table 58. Human Injection Flu Vaccine Market: Company Product Type Footprint
Table 59. Human Injection Flu Vaccine Market: Company Product Application Footprint
Table 60. Human Injection Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Human Injection Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 63. Global Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 64. Global Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Human Injection Flu Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Human Injection Flu Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 69. Global Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 70. Global Human Injection Flu Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Human Injection Flu Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Human Injection Flu Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Human Injection Flu Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 75. Global Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 76. Global Human Injection Flu Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Human Injection Flu Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Human Injection Flu Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Human Injection Flu Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 81. North America Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 82. North America Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 83. North America Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 84. North America Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 85. North America Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 86. North America Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 89. Europe Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 90. Europe Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 91. Europe Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 92. Europe Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 93. Europe Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 94. Europe Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 97. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 98. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 99. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 100. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 101. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 102. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 105. South America Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 106. South America Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 107. South America Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 108. South America Human Injection Flu Vaccine Sales Quantity by Country (2018-2023) & (Units)
Table 109. South America Human Injection Flu Vaccine Sales Quantity by Country (2024-2029) & (Units)
Table 110. South America Human Injection Flu Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Human Injection Flu Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2018-2023) & (Units)
Table 113. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2024-2029) & (Units)
Table 114. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2018-2023) & (Units)
Table 115. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2024-2029) & (Units)
Table 116. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2018-2023) & (Units)
Table 117. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2024-2029) & (Units)
Table 118. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Human Injection Flu Vaccine Raw Material
Table 121. Key Manufacturers of Human Injection Flu Vaccine Raw Materials
Table 122. Human Injection Flu Vaccine Typical Distributors
Table 123. Human Injection Flu Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Human Injection Flu Vaccine Picture
Figure 2. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Injection Flu Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Injection Flu Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. > 3 Years Examples
Figure 10. Global Human Injection Flu Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Human Injection Flu Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Human Injection Flu Vaccine Sales Quantity (2018-2029) & (Units)
Figure 13. Global Human Injection Flu Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Human Injection Flu Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Human Injection Flu Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Human Injection Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Human Injection Flu Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Human Injection Flu Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Human Injection Flu Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Human Injection Flu Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Human Injection Flu Vaccine Market Drivers
Figure 73. Human Injection Flu Vaccine Market Restraints
Figure 74. Human Injection Flu Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Human Injection Flu Vaccine
Figure 78. Human Injection Flu Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Human Injection Flu Vaccine Picture
Figure 2. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Injection Flu Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Injection Flu Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 6 Months to 3 Years Examples
Figure 9. > 3 Years Examples
Figure 10. Global Human Injection Flu Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Human Injection Flu Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Human Injection Flu Vaccine Sales Quantity (2018-2029) & (Units)
Figure 13. Global Human Injection Flu Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Human Injection Flu Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Human Injection Flu Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Human Injection Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Human Injection Flu Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Human Injection Flu Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Human Injection Flu Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Human Injection Flu Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Human Injection Flu Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Human Injection Flu Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Human Injection Flu Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Human Injection Flu Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Human Injection Flu Vaccine Market Drivers
Figure 73. Human Injection Flu Vaccine Market Restraints
Figure 74. Human Injection Flu Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Human Injection Flu Vaccine
Figure 78. Human Injection Flu Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
